Abstract
Background:Tuberculosis (TB) remains the most common cause of death in people living with HIV/AIDS. The aim of the present study was to identify predictors of mortality in TB-HIV-coinfected patients. Methods:We conducted an unmatched case-control study among a cohort of TB-HIV-coinfected adults who were on antiretroviral therapy (ART). Cases comprised 69 TB-HIV-coinfected patients who died during this period. For each case, we selected 3 (207) TB-HIV-coinfected patients who were alive during the end of the follow-up period. Results:Male sex (odds ratio [OR] = 2.04, 95% confidence interval [CI]: 1.04-4.02), being bedridden at enrollment (OR = 2.84, 95% CI: 1.17-6.89), and cough of more than 2 weeks during initiation of ART (OR = 4.75 95% CI: 2.14-10.56) were the best predictors of mortality among TB-HIV-infected patients. Conclusion:Mortality among TB-HIV-coinfected patients accounted for a considerable number of deaths among the cohort. Patients with cough at ART initiation and with poor functional status should be strictly followed to reduce death.
Original language | English |
---|---|
Journal | Journal of the International Association of Providers of AIDS Care |
Volume | 14 |
Issue number | 3 |
Pages (from-to) | 269-273 |
Number of pages | 5 |
ISSN | 2325-9574 |
DOIs | |
Publication status | Published - 2015 |
Keywords
- Viral diseases
- HIV
- AIDS
- Co-infections
- Bacterial diseases
- Tuberculosis
- Mycobacterium tuberculosis
- Epidemiology
- Mortality
- Predictors
- Gender
- Cough
- Causes of death
- Follow-up
- Ethiopia
- Africa-East